Therapeutic windows by placebo in schizophrenic patients under prolonged neuroleptic treatment
Etienne, T.; Lacroix, R.; Lacroix, J.
Presse Medicale 20(32): 1570
1991
ISSN/ISBN: 0755-4982 PMID: 1682917 Document Number: 371899
Document emailed within 1 workday
Related Documents
Spivak, B.; Mester, R.; Abesgaus, J.; Wittenberg, N.; Adlersberg, S.; Gonen, N.; Weizman, A. 1997: Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients Journal of Clinical Psychiatry 58(7): 318-322Kinon, B.J.; Kane, J.M.; Johns, C.; Perovich, R.; Ismi, M.; Koreen, A.; Weiden, P. 1993: Treatment of neuroleptic-resistant schizophrenic relapse Psychopharmacology Bulletin 29(2): 309-314
Eben, E.; Ackenheil, M.; Rüther, E. 1978: Norepinephrine turnover under neuroleptic treatment of schizophrenic syndromes Arzneimittel-Forschung 28(9): 1498
Berardi, D.; Zanfini, R.; Alessi, S.; Giannelli, A.; Ferrari, G. 1993: Neuroleptic-induced dysphoric response in non-schizophrenic patients Minerva Psichiatrica 34(2): 125-133
Morozova, M.A.; Beniashvili, A.G.; Lepilkina, T.A.; Rupchev, G.E. 2012: Double-blind placebo-controlled randomized efficacy and safety trial of add-on treatment of dimebon plus risperidone in schizophrenic patients during transition from acute psychotic episode to remission Psychiatria Danubina 24(2): 159-166
Nakazono, Y.; Abe, H.; Murakami, H.; Koyabu, N.; Isaka, Y.; Nemoto, Y.; Murata, S.; Tsutsumi, Y.; Ohtani, H.; Sawada, Y. 2005: Association between neuroleptic drug-induced extrapyramidal symptoms and dopamine D2-receptor polymorphisms in Japanese schizophrenic patients International Journal of Clinical Pharmacology and Therapeutics 43(4): 163-171
Inomata, Y. 1974: Schizophrenic patients unattended for a prolonged period Seishin Shinkeigaku Zasshi 76(7): 457-471
Karniol, I.G.; Portela, W. 1982: Oxprenolol in schizophrenic patients with tardive dyskinesia: a double-blind placebo-controlled, crossover study Brazilian Journal of Medical and Biological Research 15(6): 389-394
Langer, G.; Sachar, E.J.; Gruen, P.H. 1978: Prolactin response to neuroleptic drugs in normal and schizophrenic subjects Psychopharmacology Bulletin 14(1): 8-9
Masłowski, J. 1988: The influences of cultural and racial factors upon therapeutic response of the schizophrenic patients Psychiatria Polska 22(4): 273-278
Bralet, M.C.; Yon, V.; Loas, G.; Noisette, C. 2000: Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients L'Encephale 26(6): 32-41
Kyle, M.V.; Belcher, G.; Hazleman, B.L. 1992: Placebo controlled study showing therapeutic benefit of iloprost in the treatment of Raynaud's phenomenon Journal of Rheumatology 19(9): 1403-1406
Goldwurm, G.; Cocchi, A.; Perosino, N.; Rossella, E.; Terranova, R. 1971: Open and double-blind study of a new neuroleptic with prolonged action: pimozide (R 6238) La Clinica Terapeutica 57(5): 431-439
Caroli, F.; Baldacci-Epinette, C.; Ribeyre, P. 1993: Antidepressant treatment of schizophrenic patients L'Encephale 19(Special Issue 2): 393-396
Wiesel, F.A. 1994: Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance British Journal of Psychiatry. Suppl 23: 65-70
Axelrod, S.; Palgi, E. 1990: Developing an alliance with schizophrenic patients in day hospital treatment Bulletin of the Menninger Clinic 54(3): 340-352
Meder, J.; Tyszkowska, M.; Jarema, M.; Araszkiewicz, A.; Szafrański, T. 2008: Antipsychotics in clinical practice. the refractory schizophrenic patients treatment Psychiatria Polska 42(6): 859-873
Munn, N.A. 1993: Resolution of polydipsia and hyponatremia in schizophrenic patients after clozapine treatment Journal of Clinical Psychiatry 54(11): 439
Chouinard, G.; Annable, L.; DeMontigny, C.; Kropsky, M.L. 1977: Loxapine succinate in the treatment of newly admitted schizophrenic patients Current Therapeutic Research 21(1): 73-79
Ney, M. 1984: Responsibility of the physician with regard to the third party in the treatment of schizophrenic patients Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 135(1): 115-121